if switching from semaglutide to tirzepatide Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs and in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults Switching from full dose Semaglutide

Statistical significance was determined by one-way ANOVA followed by Bonferroni post-hoc analysis

Many patients maintain weight loss through lifestyle strategies and sometimes continue low-dose maintenance therapy to prevent rebound weight gain

Regulation of electroneutral NaCl absorption by the small intestine

3 The FLOW trial studied 3,533 adults with a mean BMI of 32, T2D, and CKD

The system was set to a flow rate of 0.060 mL/min and composed of 5 mM ammonium formate in a gradient of water/acetonitrile concentrations (all mobile phase solvents were Optima LC/MS Grade, and purchased from Fisher Scientific, Fair Lawn, NJ)